Carla Mamolo

1.8k total citations · 1 hit paper
47 papers, 1.3k citations indexed

About

Carla Mamolo is a scholar working on Hematology, Immunology and Dermatology. According to data from OpenAlex, Carla Mamolo has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 17 papers in Immunology and 14 papers in Dermatology. Recurrent topics in Carla Mamolo's work include Psoriasis: Treatment and Pathogenesis (17 papers), Dermatology and Skin Diseases (14 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Carla Mamolo is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (17 papers), Dermatology and Skin Diseases (14 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Carla Mamolo collaborates with scholars based in United States, United Kingdom and Germany. Carla Mamolo's co-authors include Joseph C. Cappelleri, Lotus Mallbris, Andrew G. Bushmakin, Melinda Gooderham, Kim Papp, Vivek S. Purohit, Robert Bissonnette, Huaming Tan, Maitreyi Raman and Yves Poulin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Carla Mamolo

46 papers receiving 1.3k citations

Hit Papers

Topical tofacitinib for atopic dermatitis: a phase II a r... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Topical tofacitinib for atopic dermatitis: a phase II a randomized trial
    2016 320 citations Robert Bissonnette, Kim Papp et al. British Journal of Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carla Mamolo United States 20 600 534 291 223 157 47 1.3k
Baker Dg United States 12 254 0.4× 617 1.2× 278 1.0× 28 0.1× 197 1.3× 22 1.1k
P.M. McHenry United Kingdom 17 558 0.9× 122 0.2× 178 0.6× 121 0.5× 25 0.2× 34 1.1k
Brittany G. Craiglow United States 23 951 1.6× 320 0.6× 194 0.7× 27 0.1× 41 0.3× 62 2.0k
Claudio Bonifati Italy 22 433 0.7× 838 1.6× 346 1.2× 38 0.2× 144 0.9× 53 1.3k
Silvia Sebastiani Italy 13 200 0.3× 408 0.8× 47 0.2× 134 0.6× 21 0.1× 42 1.3k
Lionel Bercovitch United States 25 458 0.8× 55 0.1× 380 1.3× 213 1.0× 11 0.1× 83 2.4k
Tomasz Hawro Germany 27 833 1.4× 779 1.5× 1.7k 5.7× 403 1.8× 33 0.2× 61 2.4k
M Kristensen Denmark 10 144 0.2× 257 0.5× 94 0.3× 70 0.3× 27 0.2× 18 639
Trevor Markham Ireland 14 273 0.5× 401 0.8× 128 0.4× 64 0.3× 38 0.2× 26 833
C. Nieboer Netherlands 20 543 0.9× 454 0.9× 262 0.9× 70 0.3× 43 0.3× 45 1.4k

Countries citing papers authored by Carla Mamolo

Since Specialization
Citations

This map shows the geographic impact of Carla Mamolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Mamolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Mamolo more than expected).

Fields of papers citing papers by Carla Mamolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Mamolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Mamolo. The network helps show where Carla Mamolo may publish in the future.

Co-authorship network of co-authors of Carla Mamolo

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Mamolo. A scholar is included among the top collaborators of Carla Mamolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Mamolo. Carla Mamolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nishio, Makoto, Yi‐Long Wu, Fabrice Barlési, et al.. (2024). Health-related quality of life (HRQoL) results for adjuvant alectinib vs chemotherapy in patients with resected ALK+ non-small cell lung cancer (NSCLC): Data from ALINA.. Journal of Clinical Oncology. 42(16_suppl). 8006–8006. 1 indexed citations
3.
Mamolo, Carla, et al.. (2022). Efficacy of Non-Intensive Therapies Approved for Relapsed/Refractory Acute Myeloid Leukemia: A Systematic Literature Review. Future Oncology. 18(16). 2029–2039. 4 indexed citations
4.
Crawford, Rebecca, et al.. (2022). Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review. JMIR Cancer. 8(3). e39068–e39068. 9 indexed citations
5.
Mamolo, Carla, et al.. (2021). Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting. Applied Health Economics and Health Policy. 19(6). 929–940. 3 indexed citations
6.
Mamolo, Carla, et al.. (2021). An indirect comparison between bosutinib, nilotinib and dasatinib in first-line chronic phase chronic myeloid leukemia. Current Medical Research and Opinion. 37(5). 801–809. 7 indexed citations
7.
8.
Mamolo, Carla, Verna Welch, Roland B. Walter, et al.. (2020). Budget Impact Analysis of Gemtuzumab Ozogamicin for the Treatment of CD33-Positive Acute Myeloid Leukemia. PharmacoEconomics. 39(1). 121–131. 2 indexed citations
9.
Lee, Lauren J., C.S. Kwon, Anna Forsythe, et al.. (2020). <p>Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews</p>. ClinicoEconomics and Outcomes Research. Volume 12. 693–709. 32 indexed citations
10.
Duffin, Kristina Callis, Andrew G. Bushmakin, Joseph C. Cappelleri, Lotus Mallbris, & Carla Mamolo. (2019). A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies. BMC Dermatology. 19(1). 8–8. 9 indexed citations
11.
Cortes, Jörge E., Carla Mamolo, Joseph C. Cappelleri, et al.. (2019). Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemia. Current Medical Research and Opinion. 35(9). 1615–1622. 12 indexed citations
12.
13.
Armstrong, April W., et al.. (2017). Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United States. Clinical Drug Investigation. 37(5). 493–501. 16 indexed citations
14.
Bissonnette, Robert, Kim Papp, Yves Poulin, et al.. (2016). Topical tofacitinib for atopic dermatitis: a phase II a randomized trial. British Journal of Dermatology. 175(5). 902–911. 320 indexed citations breakdown →
15.
Feldman, Steven R., Diamant Thaçi, Melinda Gooderham, et al.. (2016). Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. 75(6). 1162–1170.e3. 48 indexed citations
16.
Svedbom, Axel, Johan Dalén, Carla Mamolo, et al.. (2014). Treatment patterns with topicals, traditional systemics and biologics in psoriasis – a Swedish database analysis. Journal of the European Academy of Dermatology and Venereology. 29(2). 215–223. 31 indexed citations
17.
Bushmakin, Andrew G., Carla Mamolo, Joseph C. Cappelleri, & Michelle Stewart. (2013). The relationship between pruritus and the clinical signs of psoriasis in patients receiving tofacitinib. Journal of Dermatological Treatment. 26(1). 19–22. 31 indexed citations
18.
Cappelleri, Joseph C., Andrew G. Bushmakin, Jane Harness, & Carla Mamolo. (2013). Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity. Quality of Life Research. 22(9). 2489–2499. 35 indexed citations
19.
Mamolo, Carla, Andrew G. Bushmakin, Joseph C. Cappelleri, & Michelle Stewart. (2011). PSS17 THE EFFECT OF ORAL CP-690,550 ON PRURITUS IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS. Value in Health. 14(3). A56–A56. 1 indexed citations
20.
Mamolo, Carla, Éric Roy, Linda E. Rohr, & Pamela J. Bryden. (2006). Reaching patterns across working space: The effects of handedness, task demands, and comfort levels. Laterality Asymmetries of Body Brain and Cognition. 11(5). 465–492. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baker Dg Breakdown of academic impact, for papers by P.M. McHenry Breakdown of academic impact, for papers by Brittany G. Craiglow Breakdown of academic impact, for papers by Claudio Bonifati Breakdown of academic impact, for papers by Silvia Sebastiani Breakdown of academic impact, for papers by Lionel Bercovitch Breakdown of academic impact, for papers by Tomasz Hawro Breakdown of academic impact, for papers by M Kristensen Breakdown of academic impact, for papers by Trevor Markham Breakdown of academic impact, for papers by C. Nieboer
Rankless by CCL
2026